JP2008520705A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008520705A5 JP2008520705A5 JP2007543269A JP2007543269A JP2008520705A5 JP 2008520705 A5 JP2008520705 A5 JP 2008520705A5 JP 2007543269 A JP2007543269 A JP 2007543269A JP 2007543269 A JP2007543269 A JP 2007543269A JP 2008520705 A5 JP2008520705 A5 JP 2008520705A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- pharmaceutical composition
- hydrogen
- formula
- effective amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 14
- 239000008194 pharmaceutical composition Substances 0.000 claims 12
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 10
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 239000001257 hydrogen Substances 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 125000006239 protecting group Chemical group 0.000 claims 8
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000023275 Autoimmune disease Diseases 0.000 claims 1
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- 208000013725 Chronic Kidney Disease-Mineral and Bone disease Diseases 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 206010052779 Transplant rejections Diseases 0.000 claims 1
- AEDMQUAPBVOJNN-UHFFFAOYSA-N [3-[2-[4-[2-(trifluoromethyl)phenoxy]piperidin-1-yl]-1,3-thiazol-5-yl]-1,2,4-oxadiazol-5-yl]methanol Chemical compound O1C(CO)=NC(C=2SC(=NC=2)N2CCC(CC2)OC=2C(=CC=CC=2)C(F)(F)F)=N1 AEDMQUAPBVOJNN-UHFFFAOYSA-N 0.000 claims 1
- 210000000577 adipose tissue Anatomy 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 230000024245 cell differentiation Effects 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000007812 deficiency Effects 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 208000032839 leukemia Diseases 0.000 claims 1
- 206010025135 lupus erythematosus Diseases 0.000 claims 1
- 201000006417 multiple sclerosis Diseases 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 108090000623 proteins and genes Proteins 0.000 claims 1
- 201000006409 renal osteodystrophy Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 230000036558 skin tension Effects 0.000 claims 1
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 claims 1
- 230000035897 transcription Effects 0.000 claims 1
- 238000013518 transcription Methods 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63000704P | 2004-11-22 | 2004-11-22 | |
| PCT/US2005/041820 WO2006057901A2 (en) | 2004-11-22 | 2005-11-18 | 2-METHYLENE-19-NOR-1α-HYDROXY-17-ENE-HOMOPREGNACALCIFEROL AND ITS USES |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2008520705A JP2008520705A (ja) | 2008-06-19 |
| JP2008520705A5 true JP2008520705A5 (cg-RX-API-DMAC7.html) | 2009-01-15 |
Family
ID=36216285
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543268A Expired - Fee Related JP5161582B2 (ja) | 2004-11-22 | 2005-11-18 | １７，２０（ｚ）−デヒドロビタミンｄ類似体およびそれらの使用 |
| JP2007543269A Pending JP2008520705A (ja) | 2004-11-22 | 2005-11-18 | ２−メチレン−１９−ノル−１α−ヒドロキシ−１７−エン−ホモプレグナカルシフェロールおよびその使用 |
| JP2007543228A Expired - Fee Related JP5043673B2 (ja) | 2004-11-22 | 2005-11-18 | １７，２０（ｅ）−デヒドロビタミンｄ類似体およびそれらの使用 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543268A Expired - Fee Related JP5161582B2 (ja) | 2004-11-22 | 2005-11-18 | １７，２０（ｚ）−デヒドロビタミンｄ類似体およびそれらの使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007543228A Expired - Fee Related JP5043673B2 (ja) | 2004-11-22 | 2005-11-18 | １７，２０（ｅ）−デヒドロビタミンｄ類似体およびそれらの使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (6) | US7241752B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP1846370B1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP5161582B2 (cg-RX-API-DMAC7.html) |
| AT (3) | ATE469883T1 (cg-RX-API-DMAC7.html) |
| AU (3) | AU2005309806B2 (cg-RX-API-DMAC7.html) |
| CA (3) | CA2588410C (cg-RX-API-DMAC7.html) |
| DE (3) | DE602005021538D1 (cg-RX-API-DMAC7.html) |
| ES (3) | ES2346774T3 (cg-RX-API-DMAC7.html) |
| MX (3) | MX2007006262A (cg-RX-API-DMAC7.html) |
| NZ (3) | NZ555278A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2006057885A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030188756A1 (en) * | 2002-08-19 | 2003-10-09 | Cantorna Margherita T | Treatment of inflammatory bowel disease with vitamin d compounds |
| US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| US7244719B2 (en) * | 2004-11-22 | 2007-07-17 | Wisconsin Alumni Research Foundation | 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses |
| NZ555278A (en) * | 2004-11-22 | 2010-12-24 | Wisconsin Alumni Res Found | 17,20(e)-dehydro vitamin D analogs and their uses |
| WO2008091686A2 (en) * | 2007-01-25 | 2008-07-31 | Bioxell S.P.A. | SYNTHESIS OF 1α-FLUORO-25-HYDROXY-16-23E-DIENE-26,27-BISHOMO-20-EPI-CHOLECALCIFEROL |
| US7888339B2 (en) * | 2008-07-10 | 2011-02-15 | Wisconsin Alumni Research Foundation | 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs |
| US7893043B2 (en) * | 2008-07-10 | 2011-02-22 | Wisconsin Alumni Research Foundation | 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs |
| US20110274743A1 (en) * | 2009-01-16 | 2011-11-10 | Pharmaceutical Compounding Nz Limited | Medicament for the Treatment of Pain and Inflammation |
| US20120237472A1 (en) * | 2009-07-24 | 2012-09-20 | The Johns Hopkins University | Methods and compositions for treating or preventing autoimmune diseases using immunomodulatory agents |
| MX2012003883A (es) * | 2009-10-02 | 2012-06-27 | Wisconsin Alumni Res Found | Analogos de (20s,22e)-2-metileno-19-nor-22-ene-1a,25-dihidroxovita mina d3. |
| ES2545403T3 (es) * | 2010-03-23 | 2015-09-10 | Wisconsin Alumni Research Foundation | (20S)-2-metilen-19-nor-22-dimetil-1alfa,25-dihidroxivitamina D3 y (20R)-2-metilen-19-nor-22-dimetil-1alfa,25-hidroxivitamina D3 |
| WO2011119622A1 (en) * | 2010-03-23 | 2011-09-29 | Wisconsin Alumni Research Foundation | DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1α,25- DIHYDROXYVITAMIN D3 |
| US8664206B2 (en) | 2010-03-23 | 2014-03-04 | Wisconsin Alumni Research Foundation | Diastereomers of 2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 |
| US8410080B1 (en) * | 2011-10-21 | 2013-04-02 | Wisconsin Alumni Research Foundation | 2-methylene-vitamin D analogs and their uses |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4666634A (en) * | 1984-12-05 | 1987-05-19 | Chugai Seiyaku Kabushiki Kaisha | vitamin D3 derivatives having a substituent at 2-position |
| US5145846A (en) * | 1988-01-20 | 1992-09-08 | Hoffmann-La Roche Inc. | Vitamin D3 analogs |
| US5362719A (en) * | 1990-03-01 | 1994-11-08 | Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) | Use of vitamin-D analogues in the treatment of acne |
| GB9004544D0 (en) * | 1990-03-01 | 1990-04-25 | Leo Pharm Prod Ltd | Novel treatment ii |
| ES2070307T3 (es) * | 1990-07-04 | 1995-06-01 | Marcin Krotkiewski | Una preparacion para el tratamiento de la hipertension. |
| US5086191A (en) * | 1991-05-28 | 1992-02-04 | Wisconsin Alumni Research Foundation | Intermediates for the synthesis of 19-nor vitamin D compounds |
| GB9214202D0 (en) * | 1992-07-03 | 1992-08-12 | Leo Pharm Prod Ltd | Chemical compounds |
| DE69400495T2 (de) * | 1993-04-05 | 1997-04-30 | Wisconsin Alumni Res Found | 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle |
| US5552392A (en) * | 1993-11-03 | 1996-09-03 | Wisconsin Alumni Research Foundation | Method of treating hypoparathyroidism with (20S) vitamin D compounds |
| EP0717034B1 (en) * | 1994-12-14 | 1999-04-07 | Duphar International Research B.V | Vitamin D compounds and method of preparing these compounds |
| GB9625271D0 (en) * | 1996-12-04 | 1997-01-22 | Leo Pharm Prod Ltd | Chemical compounds |
| KR20000071039A (ko) * | 1997-02-13 | 2000-11-25 | 비숍 찰스 더블유. | 비타민 ｄ 화합물의 표적화된 치료학적 전달 |
| US5843928A (en) * | 1997-03-17 | 1998-12-01 | Wisconsin Alumni Research Foundation | 2-alkylidene-19-nor-vitamin D compounds |
| US6316642B1 (en) * | 1997-03-17 | 2001-11-13 | Wisconsin Alumni Research Foundation | 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds |
| US6392071B1 (en) * | 1997-03-17 | 2002-05-21 | Wisconsin Alumni: Research Foundation | 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds |
| US6306844B1 (en) * | 1997-03-17 | 2001-10-23 | Wisconsin Alumni Research Foundation | Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength |
| US5945410A (en) * | 1997-03-17 | 1999-08-31 | Wisconsin Alumni Research Foundation | 2-alkyl-19-nor-vitamin D compounds |
| US5936105A (en) * | 1997-06-13 | 1999-08-10 | Tetrionics, Inc. | 14-EPI-19-nor-vitamin D compounds and methods |
| DE69829279T2 (de) * | 1997-06-25 | 2006-03-30 | Teijin Ltd. | Vitamin-d3-derivate und aus diesen hergestellte heilmittel gegen entzündliche erkrankungen der atemwege |
| GB9721156D0 (en) * | 1997-10-06 | 1997-12-03 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
| ES2368824T3 (es) * | 1998-03-27 | 2011-11-22 | Oregon Health & Science University | Vitamina d y sus análogos en el tratamiento de tumores y otros desórdenes hiperproliferativos. |
| AU2001265272B2 (en) * | 2000-05-31 | 2006-08-17 | Wisconsin Alumni Research Foundation | 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds |
| CA2414407A1 (en) * | 2000-07-18 | 2002-01-24 | Bone Care International, Inc. | Stabilized 1.alpha.-hydroxy vitamin d |
| BR0113703A (pt) * | 2000-09-08 | 2003-07-22 | Wisconsin Alumni Researcg Foun | Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele |
| WO2002094247A2 (en) | 2001-05-22 | 2002-11-28 | Bioxell S.P.A. | Use of a vitamin d3 analogue for the treatment of autoimmune diabetes |
| US6627622B2 (en) | 2002-02-18 | 2003-09-30 | Wisconsin Alumni Research Foundation | (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| US6566352B1 (en) * | 2002-02-18 | 2003-05-20 | Wisconsin Alumni Research Foudation | 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses |
| DE60310050T2 (de) * | 2002-03-29 | 2007-07-05 | Wisconsin Alumni Research Foundation, Madison | Ein verfahren zur herstellung von 1-alpha-hydroxy-2-methylen-19-nor-homopregnacalciferol |
| US6846811B2 (en) * | 2002-04-22 | 2005-01-25 | Wisconsin Alumni Research Foundation | (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| GB0305332D0 (en) | 2003-03-10 | 2003-04-09 | Leuven K U Res & Dev | Biological evaluation of novel vitamin D analogues |
| US20050009792A1 (en) | 2003-07-08 | 2005-01-13 | Deluca Hector F. | (20S)-1alpha-hydroxy-2-methylene-19-nor-vitamin D3 and its uses |
| US7053075B2 (en) * | 2003-11-25 | 2006-05-30 | Deluca Hector F | Methods for reducing body fat using vitamin D compounds |
| CA2544502A1 (en) * | 2003-11-25 | 2005-06-09 | Wisconsin Alumni Research Foundation | Vitamin d analogs for obesity prevention and treatment |
| NZ555278A (en) * | 2004-11-22 | 2010-12-24 | Wisconsin Alumni Res Found | 17,20(e)-dehydro vitamin D analogs and their uses |
| CA2588406A1 (en) | 2004-11-22 | 2006-06-01 | Wisconsin Alumni Research Foundation | 2-.alpha.-methyl and 2-.beta.-methyl analogs of 19,26,27-trinor-(20s-1.alpha.-hydroxyvitamin d3 and their uses |
| WO2008035207A2 (en) | 2006-04-06 | 2008-03-27 | Wisconsin Alumni Research Foundation | 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| KR101495578B1 (ko) * | 2007-04-25 | 2015-02-25 | 사이토크로마 인코포레이티드 | 비타민 ｄ 부족 및 결핍의 치료 방법 |
-
2005
- 2005-11-18 NZ NZ555278A patent/NZ555278A/en not_active IP Right Cessation
- 2005-11-18 ES ES05849730T patent/ES2346774T3/es not_active Expired - Lifetime
- 2005-11-18 AT AT05851805T patent/ATE469883T1/de not_active IP Right Cessation
- 2005-11-18 US US11/283,291 patent/US7241752B2/en not_active Expired - Lifetime
- 2005-11-18 WO PCT/US2005/041670 patent/WO2006057885A2/en not_active Ceased
- 2005-11-18 WO PCT/US2005/041819 patent/WO2006057900A2/en not_active Ceased
- 2005-11-18 JP JP2007543268A patent/JP5161582B2/ja not_active Expired - Fee Related
- 2005-11-18 ES ES05851757T patent/ES2344989T3/es not_active Expired - Lifetime
- 2005-11-18 CA CA2588410A patent/CA2588410C/en not_active Expired - Fee Related
- 2005-11-18 MX MX2007006262A patent/MX2007006262A/es active IP Right Grant
- 2005-11-18 MX MX2007006546A patent/MX2007006546A/es active IP Right Grant
- 2005-11-18 CA CA2588401A patent/CA2588401C/en not_active Expired - Fee Related
- 2005-11-18 AU AU2005309806A patent/AU2005309806B2/en not_active Expired - Fee Related
- 2005-11-18 NZ NZ555277A patent/NZ555277A/en not_active IP Right Cessation
- 2005-11-18 EP EP05851805A patent/EP1846370B1/en not_active Expired - Lifetime
- 2005-11-18 US US11/283,125 patent/US7241750B2/en not_active Expired - Lifetime
- 2005-11-18 MX MX2007006261A patent/MX2007006261A/es active IP Right Grant
- 2005-11-18 CA CA2588396A patent/CA2588396C/en not_active Expired - Fee Related
- 2005-11-18 ES ES05851805T patent/ES2347058T3/es not_active Expired - Lifetime
- 2005-11-18 DE DE602005021538T patent/DE602005021538D1/de not_active Expired - Lifetime
- 2005-11-18 DE DE602005020842T patent/DE602005020842D1/de not_active Expired - Lifetime
- 2005-11-18 NZ NZ555282A patent/NZ555282A/en not_active IP Right Cessation
- 2005-11-18 EP EP05851757A patent/EP1828114B1/en not_active Expired - Lifetime
- 2005-11-18 AT AT05851757T patent/ATE465144T1/de not_active IP Right Cessation
- 2005-11-18 WO PCT/US2005/041820 patent/WO2006057901A2/en not_active Ceased
- 2005-11-18 EP EP05849730A patent/EP1817279B1/en not_active Expired - Lifetime
- 2005-11-18 US US11/283,090 patent/US7241748B2/en not_active Expired - Lifetime
- 2005-11-18 AU AU2005309790A patent/AU2005309790B2/en not_active Ceased
- 2005-11-18 DE DE602005021702T patent/DE602005021702D1/de not_active Expired - Lifetime
- 2005-11-18 AU AU2005309805A patent/AU2005309805B2/en not_active Ceased
- 2005-11-18 JP JP2007543269A patent/JP2008520705A/ja active Pending
- 2005-11-18 AT AT05849730T patent/ATE469127T1/de not_active IP Right Cessation
- 2005-11-18 JP JP2007543228A patent/JP5043673B2/ja not_active Expired - Fee Related
-
2007
- 2007-07-09 US US11/775,117 patent/US7704982B2/en not_active Expired - Fee Related
- 2007-07-09 US US11/775,108 patent/US7741313B2/en not_active Expired - Fee Related
- 2007-07-09 US US11/775,061 patent/US8232263B2/en not_active Expired - Fee Related